Stock Events

Stock Events

Damora Therapeutics (DMRA) Q4 2025 Earnings

6NovConfirmed

Q4 2025

-2.36

-2.03

-1.69

-1.36

Details

Expected EPS

N/A

Actual EPS

-2.36

Surprise EPS

-2.36

Surprise Percent

+∞%

Description

Damora Therapeutics (DMRA) has reported earnings of -2.36 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.